Can A Single Scientist Scramble The SSC Race?

Peter Carruthers has turned also-ran Arizona into a contender in the final lap of the supercollider marathon WASHINGTON—Seven states remain in the marathon race to be chosen as home of the superconducting supercollider, and each faces the scientific version of Heartbreak Hill this week. The challenge: a one-on-one meeting with Energy Secretary John Herrington during which each state delegation makes its pitch. Although Energy Department officials have been tight-lipped about the like

Written byJeffrey Mervis
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

WASHINGTON—Seven states remain in the marathon race to be chosen as home of the superconducting supercollider, and each faces the scientific version of Heartbreak Hill this week. The challenge: a one-on-one meeting with Energy Secretary John Herrington during which each state delegation makes its pitch.

Although Energy Department officials have been tight-lipped about the likely winner, speculation has raged for months among those involved in high-energy physics. Texas is seen as a strong contender because of its political and economic clout, and Illinois, no lightweight itself on either count, attracts support because it already has the powerful accelerator at Fermilab. But don’t count out “little” Arizona. Scheduled at random to be first across Herrington’s threshhold, the Arizona team will be representing a state that two years ago wasn’t given much of a chance to even reach the finals in the multibillion-dollar sweepstakes. But that was before Peter A. Carruthers came ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies